Skip to main content
MAZE
NASDAQ Life Sciences

Maze Q3 Loss Widens to $48M, Missing Estimates on R&D Costs

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$34.91
Mkt Cap
$1.939B
52W Low
$21.95
52W High
$53.65
52W Position info
59% above low
Off High info
35% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MAZE sits 59% above its 52-week low of $21.95.

Summary

Maze posted a Q3 net loss of $47.97 million, worse than the $46.11 million consensus from 12 analysts, and an operating loss of $51.52 million versus the -$48.98 million expected. The miss came from higher R&D spending as the MZE829 and MZE782 programs advanced, plus higher personnel and professional services costs. The company ended the quarter with $477 million in cash, which it says funds operations into 2029 — so this is a spending-rate miss, not a solvency problem. The pipeline calendar is the real story: HORIZON Phase 2 data for MZE829 is expected in early 2027, Phase 2 CIPheR topline for MZE782 in PKU in 2027, and a Phase 2 CKD trial for MZE782 starts in H1 2027.

At the time of this announcement, MAZE was trading at $34.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $21.95 to $53.65. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MAZE - Latest Insights

MAZE
Sep 22, 2026, 12:47 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $27.20
Real-time Price: $34.91 info
Change: +$7.71 (+28%) info
Market Cap: $1.939B info
MAZE
Aug 11, 2026, 4:48 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $27.50
Real-time Price: $34.91 info
Change: +$7.41 (+27%) info
Market Cap: $1.939B info
MAZE
Aug 11, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.50
Real-time Price: $34.91 info
Change: +$7.41 (+27%) info
Market Cap: $1.939B info
MAZE
May 12, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $25.78
Real-time Price: $34.91 info
Change: +$9.13 (+35%) info
Market Cap: $1.939B info
MAZE
May 12, 2026, 4:09 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $25.78
Real-time Price: $34.91 info
Change: +$9.13 (+35%) info
Market Cap: $1.939B info